knowledge -WSS

knowledge

author：knowledge 2025-10-02 21:06:45 - browse：4

Ionis Pharmaceuticals, a California biotech that has spearheaded the development of RNA-targeting medicines, announced on Tuesday that its drug against familial chylomicronemia syndrome, a rare and serious disease that prevents the body from breaking down fats, succeeded in a late-stage clinical trial.

The Phase 3 trial, dubbed Balance, enrolled 66 adults who were randomly divided into three groups and given a monthly injection of placebo or one of two doses of olezarsen, the company’s experimental drug. Treatment with the higher dose of the therapy significantly lowered triglycerides in the blood of those on the drug for six months compared to participants given placebo, though a lower dose did not have this effect. Participants on the high dose didn’t have any instances of painful inflammation of the pancreas, one of the disease’s most serious symptoms, while there were 11 such episodes among those on placebo.

Researchers reported that the treatment was also generally safe, with fewer adverse events among those on olezarsen than among the placebo group.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： CDC recommends RSV monoclonal antibody for infants

WSS

When waiting feels immoral: Empathy in the emergency department

Reframing the conversation around gain

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

How I helped Pfizer think through the ethics of Viagra

Study links childhood stress with decline in older age

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

hotspot

knowledge

focus

BioMarin wins approval for gene therapy to treat hemophilia A

Study links childhood stress with decline in older age

Sports medicine is finally prioritizing gender equality

The cancer stories no one wants to hear

Sports medicine is finally prioritizing gender equality

FDA scientists endorse Pfizer/BioNTech Covid

Medical records are filled with copy

Study links childhood stress with decline in older age

Cancer drug shortages should be causing more outrage

What is the Turing Test that determines if computers can think?

hotspot

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

How I helped Pfizer think through the ethics of Viagra

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

What is the Turing Test that determines if computers can think?

2 officers injured in shooting in Orlando, police say

Physicians aren't 'burning out.' They're suffering from moral injury

focus

explore

hotspot

hotspot